The global tetrodotoxin citrate market is anticipated to grow at a significant CAGR during the forecast period. The launch of novel medications, as well as therapeutic agents for pain relief in appropriate doses, are some elements propelling the market growth. Tetrodotoxin is a neurotoxin generated from the sea that blocks nerve and muscle action potentials by reversibly inhibiting the inward sodium current through voltage-activated sodium (Nav) channels. In electrophysiology, tetrodotoxin is often utilised to block excitability by suppressing action potential firing within neurons.
In proper doses, tetrodotoxin citrate has proven to be a potential therapeutic drug for pain relief. Tetrodotoxin citrate is not an approved medicine; however, it is shown to be quite effective as a pain reliever, which is propelling the market growth. Tetrodotoxin Citrate in suitable doses can provide significant relief. Aside from the primary causes, various constraints could obstruct the market's expansion. One of them is that, even though tetrodotoxin citrate is quite effective for pain relief, it is still not medically licenced for clinical use and has limited uses. This substance is usually found in pufferfish, and pufferfish are found in high numbers in the Asia Pacific and thus, it is the most prominent region for the tetrodotoxin citrate market.
Market Coverage :
o By Product Type
o By Application
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Detailed Segmentation :
Global Tetrodotoxin Citrate Market, By Product Type
Global Tetrodotoxin Citrate Market, By Application
Global Tetrodotoxin Citrate Market, By Geographic Region
North America
Europe
Asia-Pacific
Rest of the World